Kimberly R. Jordan, Ph.D.

2009 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
"Kimberly Jordan"


Sign in to add mentor
Jill E. Slansky grad student 2009 University of Colorado, Denver
 (The T cell response to optimal tumor peptide vaccines.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Borgers JSW, Tobin RP, Vorwald VM, et al. (2020) High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes. Immunohorizons. 4: 82-92
Tobin RP, Jordan KR, Kapoor P, et al. (2019) IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients. Frontiers in Oncology. 9: 1223
Waugh KA, Araya P, Pandey A, et al. (2019) Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome. Cell Reports. 29: 1893-1908.e4
Jordan KR, Kapoor P, Spongberg E, et al. (2017) Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients. Cancer Immunology, Immunotherapy : Cii
Buhrman JD, Jordan KR, Munson DJ, et al. (2013) Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor. The Journal of Biological Chemistry. 288: 33213-25
Jordan KR, Amaria RN, Ramirez O, et al. (2013) Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients. Cancer Immunology, Immunotherapy : Cii. 62: 1711-22
Buhrman JD, Jordan KR, U'ren L, et al. (2013) Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens. Cancer Research. 73: 74-85
Bruno TC, French JD, Jordan KR, et al. (2013) Influence of human immune cells on cancer: studies at the University of Colorado. Immunologic Research. 55: 22-33
Jordan KR, Buhrman JD, Sprague J, et al. (2012) TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines. Cancer Immunology, Immunotherapy : Cii. 61: 1627-38
Slansky JE, Jordan KR. (2010) The Goldilocks model for TCR-too much attraction might not be best for vaccine design. Plos Biology. 8
See more...